2008 American Urological Association Annual Meeting Webcasts
Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The AUA takes responsibility for the content, quality, and scientific integrity of this CME activity.
Credit Designation: The American Urological Association designates this educational activity for a maximum of 42.50 AMA PRA Category 1 Credits®. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Overview/Statement of Need/Target Audience
Urologists need a thorough knowledge of the most recent developments and techniques in Urology to ensure the highest standards of patient care.
At the conclusion of this continuing medical education activity, participants should be able to:
• describe recent developments in the medical and surgical management of urology patients
• identify new technologies for treatment of urologic problems
• report new advances in urologic research
• outline the scope and extent of urologic disease as a component of overall health care and strategies to improve patient care.
AUA Disclosure Policy
As a provider accredited by ACCME, the AUA must ensure balance, independence, objectivity and scientific rigor in all its activities.
All faculty members participating in an educational activity provided by the AUA are required to disclose to the audience any relevant financial relationships with any commercial interest to the provider. The intent of this disclosure is not to prevent faculty with relevant financial relationships from serving as faculty, but rather to provide members of the audience with information on which they can make their own judgments. The Program Planners and Scientific Planning Committee must resolve any conflicts of interest prior to the commencement of the educational activity. It remains for the audience to determine if the faculty’s relationships may influence the educational content with regard to exposition or conclusion.
Unlabeled or Unapproved Use of Drugs or Devices: It is the policy of the AUA to require the disclosure of all references to unlabeled or unapproved uses or drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to unlabeled or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
Evidence Based Content: As a provider of continuing medical education accredited by the ACCME, it is the policy of the AUA to review and certify that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
Method of Participation/Instructions
This CME activity consists of a Web cast of live scientific presentations (plenary session and courses), which were recorded during the 2008 AUA Annual Meeting. To earn credit for each presentation, please view and listen to the full lecture and accompanying slide presentation, claim the credits you spent in the activity, and complete the evaluation.
Estimated Time to Complete Entire Webcast Activity: 35.25 hours
Each educational activity within this Web cast may be completed individually. The estimated time required to complete each individual portion of this educational activity is listed in the CME information at the beginning of each individual portion of this activity.
December 31, 2009
The AUA is the sole owner of the information collected on this site. We will not sell, share, or rent this information to others in ways other than those outlined in this statement. Personal information provided by users will be used by the AUA to improve the site and provide a more personalized experience for the user, but information which identifies a specific individual will not be disclosed to others without the user's permission unless necessary to provide services which the user has requested.
AUA Confidentiality Statement Full Text: http://www.auanet.org/cme/onlineeduconf.cfm
Commercial Support Statement
The Plenary Session Webcasts are supported through an educational grant from Astellas Pharma, Inc.
The Course Webcasts are supported through educational grants as shown immediately below:
|Kidney Cancer: Recent Advances in Diagnosis and Management Pharmaceuticals
|What's New in Prostate Cancer? Practical Information on Contemporary Issues
|Erectile Dysfunction: New Concepts in Diagnosis, Prevention and Management
||Eli Lilly and Company
|Prostate Cancer Multidisciplinary Management in the Baby Boom Generation
|Kidney Cancer: New Concepts in Evaluation and Management
||Wyeth Pharmaceuticals & Genetech, Inc.
|Incontinence in Women: Objective Look at the Options
||Astellas Pharma US, Inc.
For all inquires regarding CME credit please contact:
CME Compliance Officer
American Urological Association
1000 Corporate Blvd.
Linthicum, MD 21090
Disclaimer: The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.